Healthcare Investment in India is set for a major boost as Somerset Indus Capital Partners closes its third fund. This Mumbai-based private equity firm recently secured approximately $288 million for Fund III. This total exceeds the initial target of $250 million. Consequently, the firm will prioritize improving healthcare access in Tier I and Tier II cities. They plan to invest in delivery, pharmaceuticals, medical devices, and diagnostics.

Expanding Healthcare Investment in India

The firm typically invests between $15 million and $40 million in each portfolio company. Furthermore, they can participate in larger transactions through co-investment syndication. This approach allows them to handle deals ranging from $60 million to $80 million. The fund received strong support from a diverse group of investors. These include development finance institutions, global investment firms, and insurance companies. Thus, the capital will support critical innovations in the Indian medical technology sector.

Strategic Focus on Underserved Markets

Somerset Indus aims to address the \"missing middle\" in the Indian healthcare ecosystem. Therefore, they will focus on underserved regions where quality care is often lacking. The fund has already deployed capital into three promising businesses. These include Cyrix Healthcare, Printmann Offset, and NU Hospitals. Additionally, the capital will support opportunities in preventive care and OPD-linked insurance. This strategy ensures both social impact and sustainable financial returns for the stakeholders.

Performance and Growth Strategy

The firm manages around $500 million across three different funds. Notably, Fund I has already returned four times the total capital to its investors. Meanwhile, Fund II is progressing well toward several planned exits. This proven track record underscores the firm's execution capabilities in a complex market. By partnering with scalable platforms, Somerset Indus continues to shape the future of medical services.

Frequently Asked Questions

Q1: Which sectors does Somerset Indus Fund III target?

The fund targets healthcare delivery, pharmaceuticals, medical devices, diagnostics, and allied healthcare segments.

Q2: How much capital does the firm invest per company?

Somerset Indus typically invests between $15 million and $40 million per company, with flexibility for larger deals via syndication.

Q3: What are some current investments from Fund III?

Current investments include medtech firm Cyrix Healthcare, pharmaceutical packaging company Printmann Offset, and NU Hospitals.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. PE firm Somerset Indus closes $288 million Fund III, beats target - ETHealthworld


2. Somerset Indus Capital Partners Portfolio. Available at: https://somersetinduscap.com/portfolio/


3. EY Parthenon India Q2FY26 Healthcare Sector Update.